BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28682435)

  • 41. Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
    Yin Z; Ding H; He E; Chen J; Li M
    Oncol Rep; 2016 Oct; 36(4):2033-40. PubMed ID: 27513470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
    Liu F; Xing L; Zhang X; Zhang X
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcoma.
    Liao S; Zhou S; Wang C
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30177521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
    Sun B; Yang M; Li M; Wang F
    Biomed Pharmacother; 2015 Apr; 71():58-63. PubMed ID: 25960216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA NEAT1 promotes proliferation, migration and invasion of human osteosarcoma cells.
    Li P; Huang R; Huang T; Cheng S; Chen Y; Wang Z
    Int J Med Sci; 2018; 15(11):1227-1234. PubMed ID: 30123061
    [No Abstract]   [Full Text] [Related]  

  • 49. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
    Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
    Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
    Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
    Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
    Fang J; Sun CC; Gong C
    Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNAs in osteosarcoma.
    Chen R; Wang G; Zheng Y; Hua Y; Cai Z
    Oncotarget; 2017 Mar; 8(12):20462-20475. PubMed ID: 28103585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p.
    Zhou S; Yu L; Xiong M; Dai G
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1822-1832. PubMed ID: 29229388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
    Zhang HH; Li AH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
    Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
    BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.